These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37142308)
1. Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD. Davis AK; Levin AW; Nagib PB; Armstrong SB; Lancelotta RL BMJ Open; 2023 May; 13(5):e068884. PubMed ID: 37142308 [TBL] [Abstract][Full Text] [Related]
2. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331 [TBL] [Abstract][Full Text] [Related]
3. Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial. Rucker J; Jafari H; Mantingh T; Bird C; Modlin NL; Knight G; Reinholdt F; Day C; Carter B; Young A BMJ Open; 2021 Dec; 11(12):e056091. PubMed ID: 34853114 [TBL] [Abstract][Full Text] [Related]
5. Trauma-focused psychodynamic therapy and STAIR Narrative Therapy of post-traumatic stress disorder related to childhood maltreatment: trial protocol of a multicentre randomised controlled trial assessing psychological, neurobiological and health economic outcomes (ENHANCE). Leichsenring F; Steinert C; Beutel ME; Feix L; Gündel H; Hermann A; Karabatsiakis A; Knaevelsrud C; König HH; Kolassa IT; Kruse J; Niemeyer H; Nöske F; Palmer S; Peters E; Reese JP; Reuss A; Salzer S; Schade-Brittinger C; Schuster P; Stark R; Weidner K; von Wietersheim J; Witthöft M; Wöller W; Hoyer J BMJ Open; 2020 Dec; 10(12):e040123. PubMed ID: 33334832 [TBL] [Abstract][Full Text] [Related]
6. HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer. Lewis BR; Garland EL; Byrne K; Durns T; Hendrick J; Beck A; Thielking P J Pain Symptom Manage; 2023 Sep; 66(3):258-269. PubMed ID: 37302533 [TBL] [Abstract][Full Text] [Related]
7. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants. Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888 [TBL] [Abstract][Full Text] [Related]
8. Examining the effectiveness of an intensive, 2-week treatment program for military personnel and veterans with PTSD: Results of a pilot, open-label, prospective cohort trial. Bryan CJ; Leifker FR; Rozek DC; Bryan AO; Reynolds ML; Oakey DN; Roberge E J Clin Psychol; 2018 Dec; 74(12):2070-2081. PubMed ID: 29917224 [TBL] [Abstract][Full Text] [Related]
9. Exploring Theta Burst Stimulation for Post-traumatic Stress Disorder in Australian Veterans-A Pilot Study. Nursey J; Sbisa A; Knight H; Ralph N; Cowlishaw S; Forbes D; O'Donnell M; Hinton M; Cooper J; Hopwood M; McFarlane A; Herring S; Fitzgerald P Mil Med; 2020 Sep; 185(9-10):e1770-e1778. PubMed ID: 32601710 [TBL] [Abstract][Full Text] [Related]
10. Therapist-supported online cognitive therapy for post-traumatic stress disorder (PTSD) in young people: protocol for an early-stage, parallel-group, randomised controlled study (OPTYC trial). Smith P; Ehlers A; Carr E; Clark D; Dalgleish T; Forbes G; Goldsmith K; Griffiths H; Gupta M; King D; Miles S; Plant D; Yule W; Meiser-Stedman R BMJ Open; 2022 Mar; 12(3):e054852. PubMed ID: 35314471 [TBL] [Abstract][Full Text] [Related]
11. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. Anderson BT; Danforth A; Daroff PR; Stauffer C; Ekman E; Agin-Liebes G; Trope A; Boden MT; Dilley PJ; Mitchell J; Woolley J EClinicalMedicine; 2020 Oct; 27():100538. PubMed ID: 33150319 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: an open trial. English BA; Jewell M; Jewell G; Ambrose S; Davis LL J Clin Psychopharmacol; 2006 Feb; 26(1):84-8. PubMed ID: 16415713 [TBL] [Abstract][Full Text] [Related]
15. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment. Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451 [TBL] [Abstract][Full Text] [Related]
16. Psilocybin and MDMA for the treatment of trauma-related psychopathology. Bird CIV; Modlin NL; Rucker JJH Int Rev Psychiatry; 2021 May; 33(3):229-249. PubMed ID: 34121583 [TBL] [Abstract][Full Text] [Related]
17. Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial. Ching THW; Grazioplene R; Bohner C; Kichuk SA; DePalmer G; D'Amico E; Eilbott J; Jankovsky A; Burke M; Hokanson J; Martins B; Witherow C; Patel P; Amoroso L; Schaer H; Pittenger C; Kelmendi B Front Psychiatry; 2023; 14():1178529. PubMed ID: 37181888 [TBL] [Abstract][Full Text] [Related]
18. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667 [TBL] [Abstract][Full Text] [Related]
19. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696 [TBL] [Abstract][Full Text] [Related]
20. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol. Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]